Matthias Ocker
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Emerging claudin-18.2 antagonists in the treatment of biliary tract cancer.
Journal: Expert opinion on emerging drugs
Published: June 03, 2026
The evolution of cancer therapeutics: from "undruggable" to "drugged".
Journal: Translational cancer research
Published: April 06, 2026
Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma.
Journal: Medical sciences (Basel, Switzerland)
Published: January 07, 2026
Targeted therapy for biliary tract cancer: facts and fictions as well as demands and challenges.
Journal: Expert review of anticancer therapy
Published: November 25, 2025
New frontiers in the pharmacological management of biliary tract carcinomas: the emerging role of drug conjugates.
Journal: Expert opinion on pharmacotherapy
Published: April 17, 2025
The importance of preclinical models for cholangiocarcinoma drug discovery.
Journal: Expert opinion on drug discovery
Published: January 22, 2025
Challenges and innovations in adjuvant therapy for gallbladder cancer: a meta-analytic perspective.
Journal: Hepatobiliary surgery and nutrition
Published: December 09, 2024
Enhancing anti-CD274 (PD-L1) targeting through combinatorial immunotherapy with bispecific antibodies and fusion proteins: from preclinical to phase II clinical trials.
Journal: Expert opinion on investigational drugs
Published: February 14, 2024
The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells.
Journal: PloS one
Published: February 05, 2024
Gene expression inhibitors for the treatment of liver fibrosis: drugs under preclinical and early clinical investigation.
Journal: Expert opinion on investigational drugs
Published: November 24, 2023
Identification of acetylshikonin as a novel tubulin polymerization inhibitor with antitumor activity in human hepatocellular carcinoma cells.
Journal: Journal of gastrointestinal oncology
Published: October 16, 2023
Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma.
Journal: Frontiers in cell and developmental biology
Published: October 11, 2023
Last Updated: 09/26/2026